SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Starlight who wrote (5437)1/31/1998 2:16:00 AM
From: Tharos  Respond to of 17367
 
Betty,
Quite right on the one or two drug theory, Amgen comes quickly to my mind. I tend to lean towards $50 shortly after the turn of the millenum. Could come quicker.



To: Starlight who wrote (5437)2/1/1998 7:12:00 PM
From: Jake  Read Replies (1) | Respond to of 17367
 
>ON TOPIC: I heard Michael Murphy speak last night....

If that is the case then I am receiving a mixed signal. On the hot line he has seems to be cooling off with regards to XOMA. My take is that FDA approval will take longer than he anticipated.